NASDAQ: IOSP
Innospec Inc Stock Forecast, Predictions & Price Target

Analyst price target for IOSP

Based on 1 analyst offering 12 month price targets for Innospec Inc

Min Forecast
$93.00+18.94%
Avg Forecast
$93.00+18.94%
Max Forecast
$93.00+18.94%

Should I buy or sell IOSP stock?

Based on 1 analyst offering ratings for Innospec Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their IOSP stock forecasts and price targets.

IOSP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-18

1 of 1

Forecast return on equity

Is IOSP forecast to generate an efficient return?

Company
12.33%
Industry
31.38%
Market
340.19%
IOSP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IOSP forecast to generate an efficient return on assets?

Company
8.89%
Industry
10.18%
IOSP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IOSP earnings per share forecast

What is IOSP's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$5.15
Avg 2 year Forecast
$5.68
Avg 3 year Forecast
$6.46

IOSP revenue forecast

What is IOSP's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$1.8B+1.67%
Avg 2 year Forecast
$1.9B+6.81%
Avg 3 year Forecast
$2.0B+12.28%
IOSP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IOSP revenue growth forecast

How is IOSP forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
3.4%
Industry
5.1%
Market
58.58%
IOSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IOSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IOSP vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
IOSP$78.19$93.00+18.94%Strong Buy
CC$12.95$16.80+29.73%Buy
MTX$61.94$79.50+28.35%Strong Buy
NGVT$58.87$62.50+6.17%Buy
KWR$138.99$171.00+23.03%Buy

Innospec Stock Forecast FAQ

Is Innospec Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IOSP) stock is to Strong Buy IOSP stock.

Out of 1 analyst, 1 (100%) are recommending IOSP as a Strong Buy, 0 (0%) are recommending IOSP as a Buy, 0 (0%) are recommending IOSP as a Hold, 0 (0%) are recommending IOSP as a Sell, and 0 (0%) are recommending IOSP as a Strong Sell.

If you're new to stock investing, here's how to buy Innospec stock.

What is IOSP's earnings growth forecast for 2025-2027?

(NASDAQ: IOSP) Innospec's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 14.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.45%.

Innospec's earnings in 2025 is -$1,200,000.On average, 5 Wall Street analysts forecast IOSP's earnings for 2025 to be $127,545,081, with the lowest IOSP earnings forecast at $122,381,433, and the highest IOSP earnings forecast at $131,383,129. On average, 5 Wall Street analysts forecast IOSP's earnings for 2026 to be $140,771,354, with the lowest IOSP earnings forecast at $134,765,268, and the highest IOSP earnings forecast at $145,692,182.

In 2027, IOSP is forecast to generate $159,978,936 in earnings, with the lowest earnings forecast at $149,334,487 and the highest earnings forecast at $169,367,162.

What is IOSP's revenue growth forecast for 2025-2027?

(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 3.4% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.58%.

Innospec's revenue in 2025 is $1,789,200,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2025 to be $45,070,421,658, with the lowest IOSP revenue forecast at $42,914,772,024, and the highest IOSP revenue forecast at $46,804,852,398. On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $47,349,959,202, with the lowest IOSP revenue forecast at $44,822,645,838, and the highest IOSP revenue forecast at $49,183,500,270.

In 2027, IOSP is forecast to generate $49,778,162,238 in revenue, with the lowest revenue forecast at $47,572,957,440 and the highest revenue forecast at $51,512,592,978.

What is IOSP's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: IOSP) forecast ROA is 8.89%, which is lower than the forecast US Specialty Chemicals industry average of 10.18%.

What is IOSP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IOSP price target, the average IOSP price target is $93.00, with the highest IOSP stock price forecast at $93.00 and the lowest IOSP stock price forecast at $93.00.

The Wall Street analyst predicted that Innospec's share price could reach $93.00 by Nov 18, 2026. The average Innospec stock price prediction forecasts a potential upside of 18.94% from the current IOSP share price of $78.19.

What is IOSP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IOSP) Innospec's current Earnings Per Share (EPS) is -$0.05. On average, analysts forecast that IOSP's EPS will be $5.15 for 2025, with the lowest EPS forecast at $4.94, and the highest EPS forecast at $5.30. On average, analysts forecast that IOSP's EPS will be $5.68 for 2026, with the lowest EPS forecast at $5.44, and the highest EPS forecast at $5.88. In 2027, IOSP's EPS is forecast to hit $6.46 (min: $6.03, max: $6.84).

What is IOSP's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: IOSP) forecast ROE is 12.33%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.